Evaluating a personalized exercise coaching program for cancer survivors
Official title: A Decentralized, Double-blinded, Randomized, 18 Month, Parallel-group, Superiority Study to Evaluate the Impact of Complement Theory's Live 1:1 Exercise Coaching and Personalized Digital Application on Cancer Survivors' Cost of Care
Run by Complement Theory Inc. · NCT06397651 · Data updated 2026-05-14
This study is no longer in our active list. It may have stopped recruiting or finished. The details below are as of 2026-05-14 and are kept for reference. Check ClinicalTrials.gov for its current status, or see similar studies below.
This study is testing a personalized exercise coaching program to see if it can help cancer survivors improve their health and reduce hospital visits compared to regular lifestyle tips.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 21 Years to 64 Years |
| Sex | All |
| Enrollment | 146 (estimated) |
| Sponsor | Complement Theory Inc. Industry-sponsored |
| Locations | 1 site (Dover, Delaware) |
| Trial ID | NCT06397651 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include cancer survivors aged 21 to 64 who have completed treatment within the last year and have access to a smartphone or tablet.
✕Probably not a fit
Patients who have undergone recent surgery or are deemed medically unfit for physical exercise will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This trial assesses the effectiveness of Complement Theory's personalized exercise coaching and digital application in reducing healthcare costs and improving health outcomes for cancer survivors. It employs a randomized controlled design, comparing the novel coaching approach against standard lifestyle modification resources. The program focuses on exercise, meditation, diet, sleep, and overall lifestyle changes, aiming to decrease hospitalizations and improve quality of life. The study will also explore cancer progression and recurrence in specific cancer types.
Why it matters
Potential benefit: If successful, this program could significantly reduce healthcare costs and improve the quality of life for cancer survivors.
How similar studies have gone: Other studies have shown promise in using personalized coaching and digital applications for health improvement, but this specific approach is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Cancer Type: Breast, Prostate, Colorectal, Lung and Other Cancer * Cancer Stage: Stage 1 to 4 * Treatment Status: Has undergone any cancer-related treatment in last 12 months * Age: 21 to 64 * Permission to access to last 1 year digital health records * Access to smartphone or a tablet Exclusion Criteria: * Excludes individuals who have undergone surgery within the last 4 weeks or will undergo surgery in the next 4 weeks * Participants declared medically unfit by their physicians to do physical exercise * ECOG Score 3,4 or 5
Where it's running
-
Complement Theory Inc.
Dover, Delaware, United States Recruiting
Study contacts
- Principal investigator: Claudio L. Battaglini, PhD — University of North Carolina
- Study coordinator: Anupam Anand, BTech
- Email: anupam@compthealth.com
- Phone: +918473994735
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Evaluating PC14586 for advanced solid tumors with a specific mutation
This study is testing a new oral medication called PC14586 to see if it can help people with advanced solid tumors that have a specific mutation in the TP53 gene.
-
Timing smartphone messages to boost activity for older cancer survivors with chronic pain
This study tests whether sending short smartphone messages at certain times can increase physical activity in older cancer survivors with chronic pain.
-
Holistic acupuncture to reduce chemotherapy-induced nausea
This study will test whether adding acupuncture and acupressure to standard anti-nausea medicine helps adults receiving chemotherapy who still have nausea.
-
Florida ASCENT Program
This project will test whether combining the MyCarePulse EHR platform with ASCENT patient navigators helps adults with recent cancer diagnoses in Florida improve food security, diet quality, and confidence in healthy eating compared with standard care.
-
IDOV-Immune for advanced solid tumors
This trial will try a single IV infusion of an engineered oncolytic vaccinia virus called IDOV-Immune in adults with advanced solid tumors that no longer respond to standard treatments.
-
Using Riluzole to Help Breast Cancer Survivors with Cognitive Issues
This study is testing if the medication riluzole can help breast cancer survivors who are having trouble with thinking and memory feel better.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.